ImageneBio (IMA) Operating Leases (2021 - 2025)
ImageneBio (IMA) posted Operating Leases of $713000.0 for Q4 2025, down 44.47% sequentially from $1.3 million in Q3 2025, and up 198.33% YoY from $239000.0 in Q4 2024.
ImageneBio (IMA) Operating Leases (2021 - 2025) Analysis & Trends
ImageneBio has reported Operating Leases for 5 years, with the latest figure at $713000.0 in Q4 2025.
- Quarterly Operating Leases rose 198.33% year-over-year to $713000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $713000.0 (up 198.33% YoY) and the FY2025 annual result came in at $713000.0, up 198.33% from the prior year.
- Operating Leases declined to $713000.0 in Q4 2025 per IMA's latest filing, from $1.3 million in the prior quarter.
- Over five years, Operating Leases peaked at $8.0 million in Q3 2023 and troughed at $239000.0 in Q4 2024.
- A 5-year average of $4.2 million and a median of $4.5 million in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 96.67% in 2024, then jumped 198.33% in 2025.
- Over 5 years, Operating Leases stood at $5.1 million in 2021, then decreased by 26.25% to $3.8 million in 2022, then jumped by 89.6% to $7.2 million in 2023, then slumped by 96.67% to $239000.0 in 2024, then soared by 198.33% to $713000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $713000.0, $1.3 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 239,000.00 |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 8.02 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 3.43 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 4.82 Mn |
| Dec 31, 2021 | 5.14 Mn |
| Sep 30, 2021 | 5.45 Mn |
| Jun 30, 2021 | 5.76 Mn |
| Mar 31, 2021 | 6.05 Mn |